Table 1.
Baseline characteristics in patients with all acute myocardial infarction.
| Immediate (N = 329) | Staged (N = 220) | p | |
|---|---|---|---|
| Age | 63.0 [56.0;71.0] | 61.5 [55.0;72.0] | 0.628 |
| Male | 267 (81.2%) | 196 (89.1%) | 0.017 |
| BMI | 24.6 [22.7;26.6] | 24.8 [22.9;26.9] | 0.659 |
| SBP | 130.0 [117.0;144.0] | 125.0 [110.0;140.0] | 0.009 |
| DBP | 80.0 [69.0;90.0] | 77.0 [64.0;86.5] | 0.056 |
| HR | 76.0 [66.0;85.0] | 75.0 [62.0;86.0] | 0.308 |
| Hypertension | 185 (56.2%) | 111 (50.5%) | 0.214 |
| DM | 120 (36.5%) | 58 (26.4%) | 0.017 |
| Hyperlipidemia | 135 (41.0%) | 85 (38.6%) | 0.636 |
| Current smoker | 107 (32.5%) | 84 (38.2%) | 0.203 |
| Family history of CAD | 26 (7.9%) | 13 (5.9%) | 0.471 |
| CKD | 12 (3.6%) | 4 (1.8%) | 0.322 |
| Previous CVA | 16 (4.9%) | 8 (3.6%) | 0.634 |
| Previous MI | 9 (2.7%) | 4 (1.8%) | 0.684 |
| Previous PCI | 24 (7.3%) | 12 (5.5%) | 0.498 |
| Previous CHF | 1 (0.3%) | 0 (0.0%) | 1 |
| Peripheral vascular disease | 5 (1.5%) | 1 (0.5%) | 0.449 |
| Hemoglobin | 14.4 [13.1;15.6] | 14.4 [13.1;15.6] | 0.707 |
| Creatinine | 0.9 [ 0.8; 1.1] | 1.0 [ 0.8; 1.1] | 0.028 |
| HDL | 41.0 [36.0;49.0] | 41.0 [34.0;48.0] | 0.351 |
| LDL | 122.0 [90.0;146.5] | 116.5 [87.0;141.0] | 0.397 |
| HbA1C | 6.1 [ 5.7; 7.0] | 5.9 [ 5.6; 6.5] | 0.01 |
| LVEF | 54.0 [47.0;62.0] | 53.0 [45.9;58.4] | 0.016 |
| Discharge medication | |||
| Aspirin | 326 (99.1%) | 217 (98.6%) | 0.936 |
| Warfarin or NOAC | 9 (2.7%) | 9 (4.1%) | 0.529 |
| Clopidogrel | 90 (27.4%) | 65 (29.5%) | 0.644 |
| Ticagrelor | 146 (44.4%) | 104 (47.3%) | 0.562 |
| Prasugrel | 90 (27.4%) | 49 (22.3%) | 0.214 |
| Statin | 318 (96.7%) | 215 (97.7%) | 0.637 |
| Beta blocker | 256 (77.8%) | 166 (75.5%) | 0.59 |
| ACE inhibitor or ARB | 230 (69.9%) | 145 (65.9%) | 0.372 |
| CCB | 62 (18.8%) | 28 (12.7%) | 0.075 |
Values are mean ± SD or median [25 percentile, 75 percentiles] according to distribution.
ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BNP, brain natriuretic peptide; BMI, body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; CCB, calcium channel blocker; CHF, congestive heart failure; CKD, chronic kidney disease; CVA, cerebrovascular accident; DBP, diastolic blood pressure; DM, diabetes mellitus; ESRD, end-stage renal disease; HbA1C, hemoglobin A1C; HDL-C, high-density lipoprotein cholesterol; HR, heart rate; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NOAC, new oral anticoagulant; PCI, percutaneous coronary intervention.